ANRO שווי כולל של נכסי החברה Alto Neuroscience Inc

Alto Neuroscience, Inc. (ANRO) focuses on developing neuropsychiatric treatments, facing significant scientific uncertainty and a constant need for funding. The business relies on discovering unique mechanisms of action amidst fierce competition with global pharma behemoths. Total assets of the company reach 205.97. This chart illustrates the price action of the total asset volume.

This indicator reflects the total value of Alto Neuroscience, Inc. (ANRO) resources, reverse-calculated via return on assets (ROA) while accounting for the market value of equity and liabilities. Analyzing total capital and liabilities allows for an assessment of the financial base of Alto Neuroscience, Inc. (ANRO), where asset value correlates not with market cycles, but with the stages of clinical drug trials, confirming the fundamental stability of the business.